September 04, 2020
Oncopeptides completes the extended enrollment for the pivotal phase 3 OCEAN study in relapsed refractory multiple myeloma – 495 patients included
Media
September 03, 2020
Aprea Therapeutics to Present at Upcoming Investor Conferences
September 03, 2020
Swedish Healthtech company Doctrin expands into UK
September 03, 2020
Nordic Nanovector – Mature Data from the LYMRIT 37-01 – Part A trial, Published in Blood Advances
September 02, 2020
Targovax is invited to present at Pareto Nordic Healthcare conference and RAS-targeted drug development summit
September 01, 2020
Nordic Nanovector to Present at Upcoming Pareto Securities 11[ th ]Healthcare Conference
September 01, 2020
Orexo and Lyfebulb Announce the Finalists and Jury for the 2020 Innovation Challenge in Substance Use Disorders
August 31, 2020
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
August 31, 2020
Increase of number of shares and votes in Vicore Pharma
August 29, 2020
FDA grants Priority Review of melflufen for patients with triple-class refractory multiple myeloma